What Is the Initial Imaging for a Clinically Node-Negative Axilla Before Neoadjuvant Therapy?
ACR-guided imaging workflow for Adult female or male or transfeminine (male-to-female) or transmasculine (female-to-male). Known breast cancer, clinically
ACR-guided imaging workflow for Adult female or male or transfeminine (male-to-female) or transmasculine (female-to-male). Known breast cancer, clinically
ACR-guided imaging workflow for Adult female. Surveillance following completion of breast conservation therapy for breast cancer. Negative margins. With or
ACR-guided imaging workflow for Adult female. Postsurgical excision for breast cancer. Positive margins. Asymptomatic. Initial imaging. (Imaging after Brea
ACR-guided imaging workflow for Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging
ACR-guided imaging workflow for Female. Age 30 to 39 years. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging. (Imaging afte
ACR-guided imaging workflow for Female. Age 40 years or older. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging. (Imaging a
ACR-guided imaging workflow for Adult transfeminine (male-to-female) patient younger than 30 years of age. Pathologic nipple discharge. Initial imaging. (E
ACR-guided imaging workflow for Adult transfeminine (male-to-female) patient 30 years of age or older. Pathologic nipple discharge. Initial imaging. (Evalu
ACR-guided imaging workflow for Adult female or male or transfeminine (male-to-female) or transmasculine (female-to-male). Physiologic nipple discharge. In
ACR-guided imaging workflow for Female. Suspicious axillary node on any other imaging modality (excluding mammography and ultrasound). Next imaging study.